Birznieks Gunther
- SEC CIK
- 0001702031
In the past year, 1 open-market sale filing worth $350.9K and no purchases.
Current role at each company
- VNDA Vanda Pharmaceuticals Inc.SVP, Business Developmentas of Mar 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $350.9K
- 1 filing
- Net
- −$350.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Birznieks Gunther as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Birznieks GuntherSVP, Business Development | SSale | −42.4K | $8.27 | −$350.9K | −7.9%494.2K after | |
| Mar 6, 2024 (view filing) | Mar 4-5 | 2 days | Birznieks GuntherSVP, Business Development | SSale | −17.4K | $4.22 | −$73.4K | −5.3%313.6K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Birznieks GuntherSVP, Business Development | SSale | −16.8K | $6.23 | −$104.5K | −7.5%206.0K after | 2 lots |
| Mar 2, 2022 (view filing) | Mar 1-2 | 1 day | Birznieks GuntherSVP, Business Development | SSale | −15.6K | $11.25 | −$175.5K | −7.6%188.8K after | 2 lots |